-+ 0.00%
-+ 0.00%
-+ 0.00%

Highlighting December 2025's Growth Leaders With Insider Ownership

Simply Wall St·12/15/2025 17:05:49
語音播報

As the United States stock market grapples with concerns over an AI bubble, technology shares have been under pressure, causing declines in major indices like the Nasdaq and Dow Jones Industrial Average. In such a volatile environment, companies with strong growth potential and high insider ownership can offer investors a sense of stability and alignment of interests between management and shareholders.

Top 10 Growth Companies With High Insider Ownership In The United States

Name Insider Ownership Earnings Growth
Super Micro Computer (SMCI) 13.9% 50.7%
StubHub Holdings (STUB) 14.2% 73.5%
SES AI (SES) 12% 68.9%
Prairie Operating (PROP) 29.2% 114.9%
Niu Technologies (NIU) 37.2% 93.7%
Karman Holdings (KRMN) 17.3% 78.5%
Credo Technology Group Holding (CRDO) 10.4% 30.7%
Atour Lifestyle Holdings (ATAT) 18% 24.4%
Astera Labs (ALAB) 11.7% 29.0%
AppLovin (APP) 27.4% 27.1%

Click here to see the full list of 204 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Eton Pharmaceuticals (ETON)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Eton Pharmaceuticals, Inc. is a pharmaceutical company dedicated to developing and commercializing treatments for rare diseases, with a market cap of $447.85 million.

Operations: The company's revenue is primarily derived from its segment focused on developing and commercializing prescription drug products, totaling $70.32 million.

Insider Ownership: 14.7%

Return On Equity Forecast: N/A (2028 estimate)

Eton Pharmaceuticals is poised for significant growth, with revenue expected to increase by 25.4% annually, outpacing the US market. Analysts anticipate a transition to profitability within three years, suggesting above-average market growth potential. Despite trading at 85.1% below estimated fair value and consensus on a 79.6% price rise, recent earnings show increased revenue but also higher net losses compared to the previous year. Recent shelf registration filings indicate potential capital raising efforts ahead.

ETON Earnings and Revenue Growth as at Dec 2025
ETON Earnings and Revenue Growth as at Dec 2025

Oddity Tech (ODD)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Oddity Tech Ltd. is a consumer tech company that creates digital-first brands for the beauty and wellness sectors, operating in the United States and internationally, with a market cap of $2.52 billion.

Operations: The company's revenue is derived from its Personal Products segment, totaling $780.76 million.

Insider Ownership: 21.7%

Return On Equity Forecast: 31% (2028 estimate)

Oddity Tech's revenue is forecast to grow at 16.4% annually, surpassing the US market average of 10.6%. Recent guidance revisions indicate stronger-than-expected earnings for 2025, with projected net revenue between US$806 million and US$809 million. The company launched METHODIQ, a telehealth platform aimed at expanding its dermatology offerings. Despite trading below fair value estimates, Oddity shows robust growth potential with earnings expected to outpace the broader market by growing at 17.2% annually.

ODD Earnings and Revenue Growth as at Dec 2025
ODD Earnings and Revenue Growth as at Dec 2025

Westrock Coffee (WEST)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Westrock Coffee Company, LLC is an integrated provider of coffee, tea, flavors, extracts, and ingredients solutions operating both in the United States and internationally with a market cap of $447.33 million.

Operations: The company generates revenue through its Beverage Solutions segment, which accounts for $810 million, and its Sustainable Sourcing & Traceability segment, contributing $280.67 million.

Insider Ownership: 15.4%

Return On Equity Forecast: N/A (2028 estimate)

Westrock Coffee's revenue is forecast to grow at 15.4% annually, outpacing the US market average of 10.6%. Insiders have shown confidence through substantial share purchases recently. Despite a net loss increase to US$19.1 million in Q3 2025, sales surged to US$354.83 million from US$220.86 million year-on-year, indicating strong top-line growth. The company trades significantly below its estimated fair value and aims for profitability within three years, supported by recent debt financing adjustments and private placements totaling $30 million.

WEST Earnings and Revenue Growth as at Dec 2025
WEST Earnings and Revenue Growth as at Dec 2025

Turning Ideas Into Actions

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.